NCT06229821
Not yet recruiting
Not Applicable
Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Respiratory Distress Syndrome in Premature Infant
- Sponsor
- Augusta University
- Enrollment
- 10
- Primary Endpoint
- Mechanical ventilation and supplemental oxygen
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the benefits and safety of Intrapulmonary Percussive Ventilation in preterm infants. IPV has been demonstrated to be safe, and improve airway secretions clearance and decreased atelectasis in pediatric patients. We aim to evaluate the effects of IPV in preterm infants.
Investigators
Michel Garcia Crespo
Principal Investigator
Augusta University
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Mechanical ventilation and supplemental oxygen
Time Frame: From the date of starting treatment protocol to 2 weeks after.
Need for mechanical ventilation and supplemental oxygen administration
Secondary Outcomes
- Diagnosis of Bronchopulmonary Dysplasia(At 36 weeks gestational age)
Similar Trials
Completed
Not Applicable
Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary FibrosisIdiopathic Pulmonary FibrosisNCT05366387University Hospital, Tours9
Not yet recruiting
Not Applicable
Effects of Intrapulmonary Percussive Ventilator on Respiratory FunctionAirway Clearance ImpairmentNCT06000618Shanghai 10th People's Hospital20
Completed
Not Applicable
Influence of IPV on GOR in Infants From 0 to 12 Months.Gastro-oesophageal RefluxNCT02124863Vrije Universiteit Brussel67
Terminated
Not Applicable
Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).Multiple SclerosisNCT04295616National Multiple Sclerosis Center5
Completed
Not Applicable
Analysis of the Pseudomonas aeruginosa biofilm in the respiratory samples of cystic fibrosis patientsISRCTN75391385Belgian Cystic Fibrosis Association (BCFA) (Belgium)10